1. Home
  2. OI vs SRPT Comparison

OI vs SRPT Comparison

Compare OI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo O-I Glass Inc.

OI

O-I Glass Inc.

HOLD

Current Price

$10.41

Market Cap

2.3B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.15

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OI
SRPT
Founded
1903
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
OI
SRPT
Price
$10.41
$17.15
Analyst Decision
Buy
Hold
Analyst Count
7
28
Target Price
$17.57
$25.76
AVG Volume (30 Days)
2.2M
2.0M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,426,000,000.00
$2,198,237,000.00
Revenue This Year
$3.07
N/A
Revenue Next Year
$1.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.58
52 Week Low
$9.23
$10.42
52 Week High
$16.91
$80.26

Technical Indicators

Market Signals
Indicator
OI
SRPT
Relative Strength Index (RSI) 24.09 45.46
Support Level N/A $17.05
Resistance Level $13.46 $19.55
Average True Range (ATR) 0.53 0.83
MACD -0.15 0.13
Stochastic Oscillator 1.03 63.11

Price Performance

Historical Comparison
OI
SRPT

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: